NEW ORLEANS — When using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off.  New post hoc data from Lilly’s SURMOUNT-1 trial of people […]

NEW ORLEANS — Teprotumumab (Tepezza) works equally well in both older and younger patients with thyroid eye disease (TED) and regardless of TED duration, new data […]

An alarming lack of compliance with assessments to prevent ophthalmologic and neuropathic complications associated with diabetes has been detected in nine countries in Latin America and […]

DENVER — The ability to provide adolescents with highly effective anti-obesity medications that now carry approvals from the US Food and Drug Administration (FDA) and support […]

Cardiovascular disease management is an often overlooked but critical aspect of care for people with type 1 diabetes, authors of a new review paper said. Cardiovascular […]

How can patients and clinicians effectively manage diabetic neuropathic pain in 2024? At the French Diabetes Society congress, three experts provided a comprehensive overview of the […]

DENVER — With continuous glucose monitors (CGMs) becoming vital tools for managing diabetes, the technology, soon to become available over the counter, is gaining popularity in […]